GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DHFR, FABP3, FUT7, HSPA1A, IDO1, PIM1, PPARA, PTGS2, TYR, XDH |
12.2228 |
[BP] GO:0042221 |
response to chemical
|
ADRA2A, AKR1B1, ALOX15, APP, AR, AXL, CA2, CA9, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GSK3B, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, MMP2, MMP9, NR3C1, PPARA, PTGS2, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TYR |
12.2228 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DHFR |
12.1542 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GSK3B, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TYR, XDH |
11.7377 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GSK3B, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP2, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TYR, XDH |
11.4843 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.4539 |
[BP] GO:0010033 |
response to organic substance
|
ADRA2A, AKR1B1, ALOX15, APP, AR, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GSK3B, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MMP2, NR3C1, PPARA, PTGS2, RORC, SLC6A4, SMAD3, SRC, TEK, TYR |
11.4539 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, APP, AR, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, EGFR, ESR1, ESRRA, FABP3, GSK3B, HSD17B2, IDO1, IGF1R, INSR, MMP2, MMP9, NR3C1, PPARA, PTGS2, RORC, SLC6A4, SRC, TEK, TYR |
10.7687 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA2A, AKR1B1, APP, AR, CDC25B, CSNK2A1, CYP1B1, EGFR, ESR1, ESRRA, FABP3, FLT3, HSPA1A, IDO1, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, NUAK1, PGR, PIM1, PTGS2, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
10.6338 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, APP, CBR1, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, EGFR, ESR1, FABP3, FABP4, FUT7, HSD17B1, HSD17B2, MET, PPARA, PTGS2 |
10.5664 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, FLT3, GPR35, GSK3B, HCAR2, HSPA1A, INSR, KDR, MET, MMP12, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
9.84473 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, FLT3, GPR35, GSK3B, HCAR2, HSPA1A, INSR, KDR, MET, MMP12, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
9.81651 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FLT3, GPR35, GSK3B, HCAR2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
9.68489 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, PTGS2 |
9.67121 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, PTGS2 |
9.34899 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA2A, AKR1B1, APP, AR, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, GSK3B, IGF1R, INSR, MMP2, NR3C1, PPARA, PTGS2, SLC6A4, SMAD3, SRC, TEK |
9.18396 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, PTGS2 |
9.07985 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, GPR35, GSK3B, HCAR2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
8.75226 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, ALOX15, APP, AR, AXL, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KCNH2, KDR, MMP2, MMP9, NR3C1, PTGS2, RORC, SLC6A4, SMAD3, SRC, TERT |
8.65502 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DHFR, EGFR, ESR1, F10, FABP3, FABP4, FLT3, GPR35, GSK3B, HCAR2, HSD17B1, HSD17B2, HSPA1A, INSR, KCNH2, KDR, MET, PPARA, PTGS2, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
8.50979 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, RORC, SRC |
8.39615 |
[BP] GO:0033993 |
response to lipid
|
AR, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD17B2, IDO1, NR3C1, PTGS2, RORC, SLC6A4, SRC, TYR |
8.20861 |
[BP] GO:0014070 |
response to organic cyclic compound
|
APP, AR, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, EGFR, ESR1, ESRRA, FLT3, NR3C1, PTGS2, RORC, SLC6A4, SRC, TEK, TYR |
8.16747 |
[BP] GO:0009725 |
response to hormone
|
ADRA2A, AKR1B1, AR, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, INSR, NR3C1, PPARA, PTGS2, SLC6A4, SRC, TEK |
7.98344 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, FABP3, PPARA, PTGS2 |
7.98344 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, EGFR, GSK3B, HSPA1A, IDO1, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT |
7.86208 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CES1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, ESR1, HSD17B1, HSD17B2 |
7.85522 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AXL, CSNK2A1, CYP1B1, EGFR, F10, FLT3, GPR35, GSK3B, HSPA1A, INSR, KDR, MET, MMP12, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
7.79693 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
7.77252 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, EGFR, GSK3B, HSPA1A, IDO1, IGF1R, KDR, MET, MMP9, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT |
7.76504 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, PTGS2 |
7.70849 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DHFR, GSK3B, HSD17B1, HSD17B2, IDO1, PTGS2, TYR, XDH |
7.54765 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA2, CA6, CA9, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, EGFR, ESR1, ESRRA, F10, FABP3, FABP4, FLT3, GSK3B, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, MMP12, MMP2, MMP9, NR3C1, NUAK1, PPARA, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TYR |
7.41221 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, RORC, SRC |
7.39483 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F10, FLT3, GPR35, GSK3B, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PTGS2, PTPN1, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
7.23199 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, PGR, PIM1, PPARA, RORC, SRC |
7.20172 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GSK3B, HCAR2, HSPA1A, IDO1, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
7.13155 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AXL, CSNK2A1, CYP1B1, EGFR, ESRRA, F10, FABP4, FLT3, GPR35, GSK3B, HSPA1A, IDO1, INSR, KDR, MET, MMP12, MMP2, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
7.13155 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F10, FLT3, GPR35, GSK3B, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PTGS2, PTPN1, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
7.12086 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, EGFR, GSK3B, HSPA1A, IDO1, IGF1R, KDR, MMP9, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT |
7.12086 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GSK3B, HCAR2, HSPA1A, IDO1, IGF1R, KDR, MET, MMP9, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
7.12086 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19 |
7.0998 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DHFR, EGFR, ESR1, FABP4, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KCNH2, KDR, MMP2, MMP9, NR3C1, NUAK1, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TERT |
7.08649 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, GPR35, GSK3B, HCAR2, HSPA1A, IGF1R, INSR, KCNH2, KDR, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, SLC6A4, SMAD3, SRC, TEK, TERT |
7.0847 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX15, ALOX5, CBR1, CES1, CES2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, EGFR, FABP3, FABP4, FUT7, MET, PPARA, PTGS2 |
7.07656 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AXL, CYP1B1, EGFR, F10, FLT3, GPR35, HSPA1A, INSR, KDR, MET, PTGS2, PTPN1, SRC, TEK, XDH |
6.99257 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, PTGS2 |
6.97417 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, F10, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PTGS2, PTPN1, SRC, TEK, XDH |
6.93038 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, ALOX15, APP, AR, AXL, CYP1A1, CYP1B1, EGFR, ESR1, FABP4, FLT3, GSK3B, IGF1R, INSR, KDR, MMP2, NR3C1, PTGS2, RORC, SLC6A4, SMAD3, SRC |
6.84271 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KDR, PIM1, SRC, TEK |
6.79419 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, ADRA2A, APP, CYP19A1, DHFR, DUSP3, EGFR, ESR1, FABP4, GSK3B, HSPA1A, IDO1, IGF1R, MET, MMP12, MMP2, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
6.79419 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, APP, AR, AURKB, AXL, CBR1, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GSK3B, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TYR, XDH |
6.77416 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, MMP9, PTGS2, SRC, TERT |
6.72672 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GSK3B, HCAR2, HSPA1A, IDO1, IGF1R, KDR, MMP9, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
6.563 |
[BP] GO:0032787 |
None
|
ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, FABP3, IDO1, PPARA, PTGS2 |
6.53527 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, RORC |
6.48328 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA2A, AKR1B1, AKR1B10, ALOX15, ALOX5, APP, AR, AXL, CYP19A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRB, F10, FABP4, HSD17B2, IDO1, IGF1R, INSR, KCNH2, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TYR |
6.46432 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, ADRA2A, APP, CYP19A1, CYP1B1, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
6.26191 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA2, CA9, CBR1, CDC25B, CES1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GSK3B, HSD17B2, INSR, KDR, MET, MMP2, MMP9, PGR, PIM1, PPARA, PTGS2, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TYR |
6.26191 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ADRA2A, APP, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
6.04573 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, GSK3B, HCAR2, HSPA1A, IDO1, IGF1R, KCNH2, KDR, MET, MMP12, MMP9, NR3C1, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
6.00835 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, AURKB, CDC25B, CSNK2A1, DHFR, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, PGR, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
5.87386 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ADRA2A, APP, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
5.8698 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, ADRA2A, APP, CYP19A1, CYP1B1, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
5.86125 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, APP, AR, AURKB, AXL, CBR1, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GSK3B, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TYR, XDH |
5.8145 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, GSK3B, HSPA1A, IDO1, IGF1R, KCNH2, KDR, MET, MMP12, MMP9, NR3C1, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
5.79776 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA2A, AR, DUSP3, EGFR, ESR1, ESR2, GPR35, GSK3B, HSPA1A, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SLC6A4, SMAD3, SRC, TERT, XDH |
5.76317 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ADRA2A, APP, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
5.74811 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA2A, AR, DUSP3, EGFR, ESR1, ESR2, GPR35, GSK3B, HSPA1A, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SLC6A4, SMAD3, SRC, TERT, XDH |
5.74811 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AR, AXL, CYP1B1, EGFR, ESR1, GSK3B, IGF1R, INSR, MMP2, MMP9, NR3C1, PTGS2, RORC, SLC6A4, SRC |
5.6478 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AR, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, INSR, KDR, PPARA, SMAD3, SRC, TEK, TYR |
5.6478 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DHFR, FABP3, IDO1, PIM1, PPARA, PTGS2, TYR |
5.62418 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ADRA2A, APP, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
5.58272 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, AURKB, CDC25B, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, PGR, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
5.56755 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, RORC |
5.56306 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, F10, FABP4, FLT3, GPR35, GSK3B, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP12, MMP2, MMP9, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
5.50447 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, AURKB, CDC25B, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, PGR, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH |
5.47486 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA2A, AKR1B1, AR, CDC25B, CSNK2A1, EGFR, ESR1, FLT3, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, PIM1, PTGS2, TEK, TERT |
5.47486 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
ADRA2A, AKR1B1, APP, AR, EGFR, ESR1, FLT3, GSK3B, IGF1R, INSR, MMP2, NR3C1, PTGS2, SLC6A4, SMAD3, SRC |
5.47486 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, ADRA2A, APP, CYP19A1, CYP1B1, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
5.43457 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, ADRA2A, APP, CYP19A1, CYP1B1, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
5.41614 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA2A, ALOX15, AR, CYP19A1, DUSP3, EGFR, ESR1, ESR2, GSK3B, HSPA1A, IGF1R, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
5.40532 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
APP, AR, CYP1A1, CYP1B1, EGFR, ESR1, FLT3, NR3C1, PTGS2, RORC, SLC6A4, SRC |
5.38534 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2C19, RORC |
5.35017 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, DHFR, EGFR, HSPA1A, IDO1 |
5.22714 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, AURKB, CDC25B, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, PGR, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH |
5.10542 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALOX15, APP, AR, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FLT3, GSK3B, HSD17B2, INSR, KDR, MMP9, PGR, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TYR |
5.0948 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DHFR, FABP3, IDO1, PIM1, PPARA, PTGS2, TYR |
5.05543 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GPR35, GSK3B, HCAR2, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TYR, XDH |
5.05117 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, FABP3, FABP4, FUT7, GSK3B, HSPA1A, IDO1, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
5.05117 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
5.00217 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F10, FLT3, GPR35, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
4.98265 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, ADRA2A, APP, AXL, CA2, CYP19A1, EGFR, GSK3B, HCAR2, INSR, KCNH2, MMP12, PTGS2, SLC6A4, SMAD3, SRC, TERT |
4.97723 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DHFR, FABP3, IDO1, PIM1, PPARA, PTGS2, TYR |
4.96708 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ADRA2A, ALOX15, APP, AXL, CA2, CA7, CYP19A1, EGFR, GPR35, GSK3B, HCAR2, HSPA1A, INSR, KCNH2, MMP12, MMP9, PPARA, PTGS2, PTPN1, SLC6A4, SMAD3, SRC, TERT |
4.96469 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, DHFR, EGFR, FABP3, FLT3, GSK3B, IGF1R, INSR, MMP2, PPARA, PTGS2, SLC6A4, SRC, TEK, TYR |
4.90508 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
4.90462 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
4.8861 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
4.85453 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, EGFR, ESRRB, FABP3, FLT3, INSR, KDR, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
4.85453 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, EGFR, ESRRB, FABP3, FLT3, INSR, KDR, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
4.85453 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
4.83958 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, CYP1A1, MMP2, PPARA, PTGS2, SLC6A4, SMAD3, SRC, TEK, TERT |
4.75103 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA2A, APP, AR, AXL, CA2, CYP1B1, EGFR, ESR1, ESRRA, ESRRB, GPR35, GSK3B, HCAR2, HSPA1A, IDO1, INSR, KCNH2, KDR, MET, MMP12, MMP9, PIM1, PTGS2, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
4.6642 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA |
4.65953 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, CYP1A1, MMP2, PPARA, PTGS2, SLC6A4, SMAD3, SRC, TEK, TERT |
4.64036 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA2A, ALOX15, APP, AR, EGFR, FLT3, INSR, KDR, PTPN1, SRC, TEK, XDH |
4.60097 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, APP, AURKB, AXL, CDC25B, CSNK2A1, DHFR, DUSP3, EGFR, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIM1, PTGS2, PTPN1, SRC, TEK, XDH |
4.56391 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, ADRA2A, APP, AURKB, CSNK2A1, CYP1B1, DUSP3, ESR1, FABP4, GPR35, GSK3B, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC |
4.50301 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, DHFR, EGFR, FABP3, FLT3, GSK3B, IGF1R, INSR, MMP2, PPARA, PTGS2, SLC6A4, SRC, TEK, TYR |
4.50301 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA2A, ALOX15, APP, AR, DUSP3, EGFR, FLT3, IGF1R, INSR, KDR, PTPN1, SRC, TEK, XDH |
4.49156 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIM1, SRC, TEK |
4.47592 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, ADRA2A, APP, AR, AURKB, CSNK2A1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, GSK3B, HCAR2, HSPA1A, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PGR, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TERT, XDH |
4.47109 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA2A, APP, AR, AURKB, CDC25B, CSNK2A1, DHFR, DUSP3, EGFR, ESR1, FABP4, FLT3, GSK3B, HSPA1A, IGF1R, INSR, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
4.42671 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, EGFR, ESR1, GSK3B, PGR, PPARA, RORC, SLC6A4, SRC |
4.41862 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, ADRA2A, CYP1A1, FABP3, FLT3, HCAR2, PPARA, PTGS2, RORC, SRC, TEK |
4.38718 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, CA9, CYP1A1, CYP1B1, DHFR, EGFR, FABP3, KCNH2, KDR, NR3C1, PTGS2, SLC6A2, SLC6A4, SRC |
4.37418 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.35442 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, CYP1A1, MMP2, PPARA, PTGS2, SLC6A4, SMAD3, SRC, TEK, TERT |
4.33523 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, APP, AURKB, AXL, CDC25B, CSNK2A1, DHFR, DUSP3, EGFR, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIM1, PTGS2, PTPN1, SRC, TEK, XDH |
4.22118 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA2A, AKR1B1, APP, AXL, CA12, CA2, CA7, EGFR, ESR1, FABP3, FABP4, FLT3, GPR35, INSR, KCNH2, MET, SMAD3, SRC, TERT |
4.17754 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, EGFR, ESRRB, FLT3, INSR, KDR, MMP9, PTGS2, PTPN1, SRC, TEK, XDH |
4.17156 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, DUSP3, EGFR, ESRRB, FABP4, FLT3, IGF1R, INSR, KDR, MMP9, PPARA, PTGS2, PTPN1, SRC, TEK, XDH |
4.13078 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, CA2, CYP1A1, EGFR, HSPA1A, MMP2, PPARA, PTGS2, SLC6A4, SMAD3, SRC, TEK, TERT, TYR |
4.09211 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRA2A, APP, AR, AURKB, CDC25B, CSNK2A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, FABP4, FLT3, GPR35, GSK3B, HSPA1A, IGF1R, INSR, MET, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
4.04607 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, HSPA1A, IDO1, MMP12, MMP2, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
4.02617 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, PTGS2, TERT |
4.025 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA2A, APP, AR, AXL, CA2, CYP1B1, EGFR, ESRRB, HCAR2, HSPA1A, IDO1, KDR, MET, MMP12, MMP9, PIM1, PTGS2, SMAD3, SRC, TEK, TERT |
4.00715 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, CYP1A1, DHFR, EGFR, PPARA, SMAD3 |
4.00715 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, APP, CA2, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2, TERT |
4.00238 |
[BP] GO:0030518 |
intracellular steroid hormone receptor signaling pathway
|
AR, ESR1, ESR2, NR3C1, PGR, SRC |
3.97055 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, DHFR, EGFR, FABP3, HSD17B2, KDR, MMP2, PTGS2, SLC6A4, SRC |
3.97055 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SRC, TEK |
3.92375 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
3.91165 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DHFR, EGFR, INSR, PTGS2, SLC6A2, SLC6A4, SMAD3 |
3.87006 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, ADRA2A, AKR1B1, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, HCAR2, HSD17B1, HSD17B2 |
3.84099 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
ADRA2A, AR, DUSP3, EGFR, ESR1, ESR2, GSK3B, HSPA1A, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SMAD3, SRC, TERT, XDH |
3.79776 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, EGFR, FLT3, INSR, KDR, MMP9, PTGS2, PTPN1, SRC, TEK, XDH |
3.76135 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
3.7574 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRA2A, APP, AR, AURKB, CDC25B, DHFR, EGFR, ESR1, ESR2, FLT3, GSK3B, HSPA1A, INSR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
3.73638 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, GSK3B, IGF1R, INSR, PPARA, PTGS2, SRC, TEK |
3.67954 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, CSNK2A1, EGFR, ESR1, FLT3, GSK3B, HSPA1A, INSR, KDR, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
3.66513 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, APP, AR, AXL, CDC25B, CYP19A1, CYP1A1, EGFR, ESR1, ESRRB, HSD17B2, IDO1, INSR, MMP2, MMP9, PGR, PTGS2, SLC6A4, SRC |
3.61438 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, GSK3B, MET, MMP9, PPARA, SRC, TERT |
3.60855 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.56592 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.56592 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA |
3.56592 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, EGFR, KCNH2, KDR, NR3C1, PTGS2, SRC |
3.54827 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, DHFR, DUSP3, EGFR, GSK3B, HSPA1A, IGF1R, MET, NUAK1, PTGS2, PTPN1, TERT, XDH |
3.54827 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, EGFR, F10, INSR, MET, SRC, TEK, XDH |
3.53121 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, MMP9, PTGS2, PTPN1, SRC, TEK, XDH |
3.52767 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
3.52767 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.52393 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AR, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, INSR, KDR, MET, MMP12, NR3C1, PGR, PPARA, PTGS2, RORC, SMAD3, SRC, TERT |
3.51839 |
[BP] GO:0010906 |
None
|
ESRRB, GSK3B, INSR, PPARA, RORC, SRC |
3.50442 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APP, AURKB, CDC25B, CYP1A1, DUSP3, EGFR, INSR, SLC6A4, SRC, TERT |
3.48554 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, EGFR, ESR1, FLT3, GSK3B, HSPA1A, INSR, KDR, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
3.47991 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, F10, INSR, MET, SRC, TEK |
3.46501 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA2A, EGFR, PTGS2, SLC6A4, SRC, TEK |
3.41718 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK |
3.40372 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.37774 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
3.37038 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, IDO1, PPARA, PTGS2, SMAD3, TEK |
3.33832 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AR, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, IGF1R, INSR, MET, MMP12, NR3C1, PGR, PPARA, PTPN1, RORC, SMAD3, SRC, TERT |
3.31487 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, APP, AR, AURKB, AXL, ESR1, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, SMAD3, SRC, TEK |
3.29538 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APP, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DHFR, EGFR, GSK3B, HSPA1A, IDO1, MMP2, MMP9, NUAK1, PPARA, PTGS2, PTPN1, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT |
3.28905 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, EGFR, GSK3B, IGF1R, INSR, MMP2, PTGS2, SLC6A4, SRC |
3.27994 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, APP, AR, AURKB, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GSK3B, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
3.27172 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, EGFR |
3.27157 |
[BP] GO:0010605 |
negative regulation of macromolecule metabolic process
|
APP, AR, AURKB, CSNK2A1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, GSK3B, HSPA1A, IGF1R, KDR, MMP12, MMP9, NR3C1, PGR, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TERT, XDH |
3.26237 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC |
3.256 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, APP, AR, CYP1B1, FABP3, HSPA1A, IDO1, PTGS2, SLC6A4, SMAD3, TERT, XDH |
3.23972 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
AR, AXL, CDC25B, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, INSR, PGR, PTGS2, SRC |
3.21426 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
CYP1B1, DHFR, EGFR, INSR, PTGS2, SMAD3, XDH |
3.20946 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA2A, AKR1B1, APP, CA12, CA2, CA7, EGFR, ESR1, FABP3, FABP4, GPR35, INSR, KCNH2, MET, SMAD3 |
3.18854 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
3.16312 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, DUSP3, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PTGS2, PTPN1, SRC, TEK, XDH |
3.1542 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX15, APP, CES1, CYP19A1, CYP1A1, CYP1B1, DHFR, TYR |
3.12617 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AR, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, INSR, MET, MMP12, NR3C1, PGR, PPARA, PTGS2, RORC, SMAD3, SRC, TERT |
3.12386 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, CA9, CSNK2A1, EGFR, NR3C1, SRC |
3.07319 |
[BP] GO:0010907 |
None
|
ESRRB, INSR, PPARA, SRC |
3.02322 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRA2A, ALOX15, APP, AR, AURKB, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GSK3B, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH |
3.02122 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AR, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, IGF1R, INSR, KDR, MET, MMP12, NR3C1, PGR, PPARA, RORC, SMAD3, SRC, TERT |
3.01595 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, EGFR, GSK3B, IGF1R, INSR, MMP2, PTGS2, SLC6A4, SRC |
3.01152 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, EGFR, PTGS2 |
3.00036 |
[BP] GO:0010675 |
None
|
ESRRB, GSK3B, INSR, PPARA, RORC, SRC |
3.00036 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
3.00036 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, APP, AR, AURKB, CA9, CDC25B, CSNK2A1, CYP1A2, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
3.00036 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, ADRA2A, DUSP3, EGFR, FLT3, IGF1R, INSR, PTPN1, SRC |
2.9935 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, PTGS2, SRC, TEK |
2.9702 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, AXL, CYP1B1, EGFR, HSPA1A, MMP9, PTGS2, SRC |
2.9702 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, GSK3B, MET, MMP9, PPARA, SMAD3, SRC, TERT |
2.9702 |
[BP] GO:0032355 |
response to estradiol
|
CYP1A2, EGFR, ESR1, ESRRA, PTGS2, SLC6A4 |
2.95322 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA2A, AKR1B1, APP, AR, AXL, CA1, CA2, CSNK2A1, CYP1B1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, GSK3B, HCAR2, IGF1R, INSR, KCNH2, KDR, MET, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK |
2.94036 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, EGFR |
2.93852 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC, TEK |
2.93852 |
[BP] GO:0071383 |
None
|
AR, EGFR, FLT3, NR3C1, SRC |
2.92088 |
[BP] GO:0042738 |
exogenous drug catabolic process
|
CYP1A2, CYP2A6, CYP2C19 |
2.89759 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, PTGS2, TERT |
2.88492 |
[BP] GO:0051172 |
None
|
ADRA2A, APP, AR, AURKB, CSNK2A1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, HSPA1A, IGF1R, MMP12, MMP9, NR3C1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TERT, XDH |
2.88456 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, CYP1A1, EGFR, ESR1, FLT3, MET, PIM1, SRC, TEK, TYR |
2.88456 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
2.87275 |
[BP] GO:0048609 |
multicellular organismal reproductive process
|
AKR1B1, APP, AR, AXL, CYP1A1, EGFR, ESR1, PGR, PTGS2, SLC6A4, SRC |
2.87028 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, ADRA2A, APP, AURKB, CDC25B, DUSP3, EGFR, FABP4, FLT3, GSK3B, IGF1R, INSR, PTPN1, SRC, TEK |
2.87028 |
[BP] GO:0071396 |
cellular response to lipid
|
AR, AXL, EGFR, ESR1, FLT3, NR3C1, RORC, SLC6A4, SRC |
2.86592 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRA2A, APP, AURKB, CDC25B, DHFR, EGFR, ESR1, FLT3, GSK3B, HSPA1A, INSR, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
2.86504 |
[BP] GO:1900182 |
positive regulation of protein localization to nucleus
|
APP, EGFR, PTGS2, SMAD3, SRC, TERT |
2.86174 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.85638 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, DUSP3, EGFR, KDR, PTPN1, SRC, TEK |
2.83788 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, IDO1, KDR, MET, MMP12, PPARA, PTGS2, SMAD3, TEK |
2.8133 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.8133 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, APP, AR, AXL, CBR1, CDC25B, CES1, CYP1A1, EGFR, ESR1, ESRRB, FABP4, FLT3, FUT7, GSK3B, KDR, MET, MMP2, MMP9, PGR, PTGS2, RORC, SMAD3, SRC, TEK, TERT |
2.78334 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, AOX1, APP, AR, AURKB, AXL, CDC25B, CSNK2A1, CYP1A1, CYP1A2, DHFR, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, GSK3B, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TYR, XDH |
2.77101 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
ADRA2A, APP, AR, AURKB, CSNK2A1, DHFR, DUSP3, ESR1, ESR2, ESRRA, FABP4, GSK3B, HSPA1A, IGF1R, MET, MMP12, MMP9, NR3C1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TERT, XDH |
2.76564 |
[BP] GO:1901655 |
None
|
AKR1B1, AR, EGFR, NR3C1, SRC |
2.76564 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, ADRA2A, CSNK2A1, EGFR, ESRRB, GSK3B, HCAR2, HSPA1A, INSR, KDR, MET, PPARA, PTPN1, SMAD3 |
2.7643 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
AR, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.7626 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA2A, EGFR, PTGS2, SLC6A4, SRC, TEK |
2.74928 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.72415 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, CSNK2A1, DHFR, DUSP3, EGFR, ESR1, FABP4, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
2.72398 |
[BP] GO:1904407 |
positive regulation of nitric oxide metabolic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.72009 |
[BP] GO:0045429 |
positive regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.72009 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, ADRA2A, AURKB, CA2, CA7, EGFR, HCAR2, KDR, PTGS2, SRC |
2.69781 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, ADRA2A, GPR35, KCNH2, MMP9, PTGS2 |
2.69522 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
AR, HSPA1A, MMP9, PTGS2, PTPN1, SRC, TERT |
2.68131 |
[BP] GO:2001233 |
regulation of apoptotic signaling pathway
|
AR, GSK3B, HSPA1A, MMP9, PTGS2, PTPN1, SMAD3, SRC, TERT |
2.67519 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, ADRA2A, APP, CA2, EGFR, GSK3B, HCAR2, MMP12, PTGS2, PTPN1, SMAD3, SRC |
2.67519 |
[BP] GO:0051254 |
None
|
APP, AR, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, INSR, MET, MMP12, NR3C1, PGR, PPARA, RORC, SMAD3, SRC, TERT |
2.66258 |
[BP] GO:0042058 |
None
|
ADORA1, ADRA2A, APP, EGFR, MMP9 |
2.66258 |
[BP] GO:0045931 |
positive regulation of mitotic cell cycle
|
APP, CDC25B, CYP1A1, DUSP3, INSR, TERT |
2.65275 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
2.65064 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, EGFR, FLT3, INSR, KDR, MMP9, PTGS2, PTPN1, SRC, TEK, XDH |
2.6339 |
[BP] GO:0044089 |
positive regulation of cellular component biogenesis
|
ALOX15, ESR1, GSK3B, HSPA1A, KDR, MET, MMP1, SMAD3, SRC, TEK |
2.62846 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, ADRA2A, ALOX15, APP, AR, AURKB, CA9, CDC25B, CSNK2A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH |
2.62605 |
[BP] GO:0048545 |
response to steroid hormone
|
AR, CA2, EGFR, FLT3, NR3C1, PTGS2, SRC |
2.59456 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, CA2, CA7, EGFR, PTGS2, SLC6A4 |
2.59412 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, CA2, CA7, EGFR, PTGS2, SLC6A4 |
2.59412 |
[BP] GO:0001954 |
positive regulation of cell-matrix adhesion
|
GSK3B, KDR, SMAD3, TEK |
2.58342 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
EGFR, INSR, PTGS2, SMAD3, XDH |
2.58342 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, APP, AR, AURKB, CA9, CDC25B, CSNK2A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH |
2.57992 |
[BP] GO:1900180 |
regulation of protein localization to nucleus
|
APP, EGFR, GSK3B, PTGS2, SMAD3, SRC, TERT |
2.57992 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.57992 |
[BP] GO:0070920 |
None
|
EGFR, ESR1, TERT |
2.57992 |
[BP] GO:0019372 |
lipoxygenase pathway
|
ALOX15, ALOX5, PTGS2 |
2.57992 |
[BP] GO:0042136 |
neurotransmitter biosynthetic process
|
ACHE, CYP1B1, DHFR, SLC6A4 |
2.55673 |
[BP] GO:0031334 |
positive regulation of protein complex assembly
|
ALOX15, ESR1, GSK3B, HSPA1A, MET, MMP1, SRC |
2.5386 |
[BP] GO:0010628 |
positive regulation of gene expression
|
APP, AR, EGFR, ESR1, ESR2, ESRRA, ESRRB, GSK3B, HSPA1A, INSR, MET, MMP12, NR3C1, PGR, PPARA, RORC, SLC6A4, SMAD3, SRC, TERT |
2.5158 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, ADRA2A, APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, PTPN1, SRC, TEK |
2.51047 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, AURKB, GSK3B, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
2.50284 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
HSPA1A, MMP9, PTGS2, PTPN1, SRC |
2.49166 |
[BP] GO:0050730 |
None
|
ADORA1, ADRA2A, APP, EGFR, FLT3, PTPN1, SRC |
2.47589 |
[BP] GO:0060748 |
None
|
AR, PGR |
2.46504 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.46504 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.46504 |
[BP] GO:0032227 |
negative regulation of synaptic transmission, dopaminergic
|
PTGS2, SLC6A4 |
2.46504 |
[BP] GO:0050793 |
regulation of developmental process
|
APP, AR, AXL, CA2, CYP1B1, EGFR, ESR1, ESRRA, ESRRB, GSK3B, IDO1, INSR, KDR, NUAK1, PIM1, PPARA, PTGS2, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
2.44877 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
DUSP3, ESR1, HSPA1A, IGF1R, MET, MMP9, PTGS2, PTPN1, SRC, XDH |
2.44877 |
[BP] GO:0045893 |
None
|
APP, AR, EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MET, MMP12, NR3C1, PGR, PPARA, RORC, SMAD3, SRC, TERT |
2.43222 |
[BP] GO:1903508 |
None
|
APP, AR, EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MET, MMP12, NR3C1, PGR, PPARA, RORC, SMAD3, SRC, TERT |
2.43222 |
[BP] GO:1902680 |
None
|
APP, AR, EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MET, MMP12, NR3C1, PGR, PPARA, RORC, SMAD3, SRC, TERT |
2.42971 |
[BP] GO:1901184 |
None
|
ADORA1, ADRA2A, APP, EGFR, MMP9 |
2.42606 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, ALOX15, CES1, CYP19A1, DHFR, TYR |
2.42523 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, XDH |
2.42523 |
[BP] GO:0000904 |
cell morphogenesis involved in differentiation
|
AR, AXL, MET, SRC, TEK |
2.40913 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CSNK2A1, EGFR, F10, FLT3, GSK3B, IGF1R, INSR, KDR, MET, SRC, TEK |
2.39497 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.39497 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.39497 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, MET, SRC |
2.39497 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, MET, SRC |
2.39497 |
[BP] GO:1903428 |
positive regulation of reactive oxygen species biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.39082 |
[BP] GO:0010676 |
None
|
ESRRB, INSR, PPARA, SRC |
2.39082 |
[BP] GO:0050994 |
None
|
ADORA1, ADRA2A, HCAR2, PPARA |
2.39082 |
[BP] GO:0048732 |
gland development
|
AR, CSNK2A1, CYP19A1, EGFR, INSR, SMAD3, TYR |
2.38287 |
[BP] GO:0050678 |
None
|
AR, EGFR, KDR, MMP12, PGR, SMAD3, TEK, XDH |
2.37402 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
GSK3B, KDR, SMAD3, SRC, TEK |
2.362 |
[BP] GO:0071363 |
cellular response to growth factor stimulus
|
APP, EGFR, INSR, KDR, NR3C1, SMAD3, SRC |
2.35306 |
[BP] GO:2000026 |
regulation of multicellular organismal development
|
APP, AR, AXL, CA2, CYP1B1, EGFR, ESR1, ESRRA, GSK3B, IDO1, INSR, KDR, PIM1, PTGS2, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
2.3375 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.33489 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.33489 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CYP19A1, MMP12, PPARA, SMAD3, TEK |
2.31922 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, ADRA2A, APP, AR, CSNK2A1, EGFR, GSK3B, HCAR2, MMP12, PTGS2, PTPN1, SMAD3, SRC, TERT |
2.31761 |
[BP] GO:0010811 |
positive regulation of cell-substrate adhesion
|
ALOX15, GSK3B, KDR, SMAD3, TEK |
2.31388 |
[BP] GO:0051726 |
regulation of cell cycle
|
APP, AURKB, CDC25B, CSNK2A1, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, PIM1, PTGS2, SLC6A4, SMAD3, SRC, TERT |
2.30869 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX15, ALOX5, CES1, CYP19A1, CYP1A1, DHFR, IDO1, PTGS2 |
2.29232 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APP, AURKB, CDC25B, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, TERT |
2.29005 |
[BP] GO:0006109 |
regulation of carbohydrate metabolic process
|
ESRRB, GSK3B, INSR, PPARA, RORC, SRC |
2.28741 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC |
2.28741 |
[BP] GO:0046686 |
response to cadmium ion
|
CYP1A2, EGFR, MMP9, TERT |
2.28741 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.28274 |
[BP] GO:0032870 |
cellular response to hormone stimulus
|
ADRA2A, AR, EGFR, ESR1, FLT3, INSR, NR3C1, SRC |
2.28059 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.26318 |
[BP] GO:0045428 |
regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.26318 |
[BP] GO:0009896 |
positive regulation of catabolic process
|
ADRA2A, CSNK2A1, ESRRB, GSK3B, HSPA1A, INSR, KDR, PPARA, PTPN1 |
2.26073 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX15, CES1, CSNK2A1, CYP19A1, CYP1A1, HSD17B1, HSD17B2, PTGS2 |
2.25756 |
[BP] GO:0010629 |
None
|
APP, AR, AURKB, DHFR, ESR1, ESR2, ESRRA, FABP4, HSPA1A, KDR, MMP12, NR3C1, PGR, PPARA, RORC, SMAD3, SRC, TERT, XDH |
2.24995 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, ADRA2A, APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, PTPN1, SRC |
2.24881 |
[BP] GO:0030155 |
regulation of cell adhesion
|
ALOX15, CYP1B1, DUSP3, GSK3B, IDO1, KDR, NUAK1, PPARA, SMAD3, SRC, TEK |
2.24768 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.23482 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.23482 |
[BP] GO:0050995 |
None
|
ADORA1, ADRA2A, HCAR2 |
2.23482 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.23482 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.23482 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.23482 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, CSNK2A1, DHFR, DUSP3, EGFR, ESR1, FABP4, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
2.21689 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, ADRA2A, EGFR, HCAR2, MET, PPARA, SMAD3 |
2.20399 |
[BP] GO:0048729 |
tissue morphogenesis
|
AR, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.20062 |
[BP] GO:0001503 |
ossification
|
ALOX15, EGFR, MMP2, MMP9, TEK |
2.19965 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, ADRA2A, EGFR, FLT3, INSR, PTPN1, SRC |
2.19717 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.189 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, PPARA, SMAD3, TEK |
2.18514 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2 |
2.17317 |
[BP] GO:0048608 |
reproductive structure development
|
AR, AXL, CYP19A1, ESR1, HSD17B2, INSR, SRC |
2.14343 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.14343 |
[BP] GO:0010810 |
regulation of cell-substrate adhesion
|
ALOX15, GSK3B, KDR, SMAD3, SRC, TEK |
2.14126 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.14126 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.14126 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, PTGS2, SLC6A4 |
2.10288 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, ALOX15, APP, AXL, CA2, CYP19A1, DUSP3, ESR1, ESRRA, HCAR2, HSPA1A, IDO1, MMP12, MMP2, PTPN1, SMAD3, SRC |
2.09225 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.07885 |
[BP] GO:0044248 |
cellular catabolic process
|
ACHE, AKR1B10, AOX1, AURKB, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, FABP3, FABP4, GSK3B, HSPA1A, IDO1, SRC, XDH |
2.06874 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
EGFR, FABP4, IDO1, KDR, MET, PTGS2, SMAD3 |
2.06874 |
[BP] GO:0070848 |
response to growth factor
|
APP, EGFR, INSR, KDR, NR3C1, SMAD3, SRC |
2.06874 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA2A, EGFR, PTGS2, SLC6A4 |
2.05246 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA2A, EGFR, PTGS2, SLC6A4 |
2.05246 |
[BP] GO:0051222 |
positive regulation of protein transport
|
ACHE, APP, EGFR, GSK3B, HCAR2, MMP12, PTGS2, SMAD3, SRC |
2.05246 |
[BP] GO:0005979 |
None
|
ESRRB, GSK3B, INSR |
2.05246 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.05246 |
[BP] GO:0010962 |
None
|
ESRRB, GSK3B, INSR |
2.05246 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, EGFR, KDR, SRC, TEK |
2.05049 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CES1, CYP19A1, HSD17B1, HSD17B2 |
2.02822 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, FABP4, FUT7, GSK3B, HSPA1A, IDO1, XDH |
2.02139 |
[BP] GO:0045913 |
None
|
ESRRB, INSR, PPARA, SRC |
2.02088 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, EGFR, HCAR2, MMP12, SLC6A4, SRC |
2.02058 |
[BP] GO:1904646 |
cellular response to amyloid-beta
|
APP, GSK3B, IGF1R |
2.01208 |
[BP] GO:0051094 |
positive regulation of developmental process
|
APP, AR, AXL, CA2, CYP1B1, ESRRB, IDO1, INSR, KDR, PIM1, PTGS2, SMAD3, SRC, TEK, TERT |
2.00254 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, IDO1 |
2.00048 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, APP, AR, AURKB, CA1, CA2, CA4, CA5A, CA5B, CA7, CBR1, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DHFR, DUSP3, EGFR, ESR1, ESR2, F10, FABP3, FABP4, FLT3, FUT7, GSK3B, HSD17B1, HSD17B2, HSPA1A, IDO1, INSR, KCNH2, KDR, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PTGS2, PTPN1, SLC6A4, SMAD3, SRC, TERT, TYR, XDH |
3.53121 |
[CC] GO:0045121 |
membrane raft
|
APP, EGFR, INSR, KDR, PTGS2, SLC6A2, SLC6A4, SRC, TEK |
3.44257 |
[CC] GO:0098857 |
membrane microdomain
|
APP, EGFR, INSR, KDR, PTGS2, SLC6A2, SLC6A4, SRC, TEK |
3.42061 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, ADRA2A, CA2, CA4, CA9, EGFR, TEK |
2.9702 |
[CC] GO:0098589 |
membrane region
|
APP, EGFR, INSR, KDR, PTGS2, SLC6A2, SLC6A4, SRC, TEK |
2.87858 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, EGFR, F10, FLT3, HSD17B2, NR3C2, PTGS2, PTPN1 |
2.83757 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, APP, AR, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, EGFR, ESR1, F10, FLT3, GPR35, GSK3B, HCAR2, IGF1R, INSR, KCNH2, KDR, MET, MMP2, PIM1, PTPN1, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT |
2.5489 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, AOX1, APP, AR, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PTPN1, RORC, SMAD3, TYR, XDH |
22.8726 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
16.5745 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX15, ALOX5, AOX1, APP, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DHFR, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, GSK3B, HSD17B1, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TYR, XDH |
15.1952 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DHFR, DUSP3, EGFR, F10, FLT3, FUT7, GSK3B, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PTGS2, PTPN1, SRC, TEK, TERT, TYR, XDH |
11.9179 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PPARA, PTPN1, RORC, SMAD3 |
11.5634 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.5464 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, AOX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, F10, IDO1, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, SMAD3, TERT, TYR, XDH |
10.4334 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, RORC |
10.2713 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, AOX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, F10, IDO1, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, SMAD3, TERT, TYR, XDH |
10.1186 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
9.31656 |
[MF] GO:0005496 |
steroid binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, HSD17B1, NR3C1, NR3C2, PGR, RORC |
8.75226 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DHFR, HSD17B1, HSD17B2, IDO1, PTGS2, TYR, XDH |
8.1478 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, PGR, PPARA, RORC |
7.87705 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, PGR, PPARA, RORC |
7.87705 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, XDH |
7.56847 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, IDO1, PTGS2, SRC |
7.25651 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
7.15411 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, IDO1, PTGS2, SRC |
7.03294 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, AR, AXL, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, HCAR2, IGF1R, INSR, KCNH2, KDR, MET, NR3C1, NR3C2, PGR, PPARA, RORC, TEK |
6.60954 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
6.57176 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
6.45905 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
5.93254 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, TYR |
5.86125 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA2A, AR, AXL, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, HCAR2, IGF1R, INSR, KCNH2, KDR, MET, NR3C1, NR3C2, PGR, PPARA, RORC, TEK |
5.67391 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DHFR, HSD17B1, IDO1, PTGS2, SRC, XDH |
5.63019 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA2A, AR, AXL, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, HCAR2, IGF1R, INSR, KCNH2, KDR, MET, NR3C1, NR3C2, PGR, PPARA, RORC, SMAD3, TEK |
5.56259 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, HSD17B1, NR3C1, NR3C2, PGR, PPARA, RORC |
5.50857 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2C19, DHFR, EGFR, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, SLC6A4, SRC, TEK |
5.50447 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, PTGS2, TYR |
5.49055 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA2A, AR, AXL, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, HCAR2, IGF1R, INSR, KCNH2, KDR, MET, NR3C1, NR3C2, PGR, PPARA, RORC, TEK |
5.47486 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2C19 |
5.24754 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
5.19783 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
4.98265 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, EGFR, HSD17B1, IGF1R, INSR, NR3C1 |
4.9778 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIM1, SRC, TEK |
4.9646 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, ADRA2A, CSNK2A1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SLC6A4, SMAD3, SRC |
4.84962 |
[MF] GO:0019899 |
enzyme binding
|
ADRA2A, APP, AR, AURKB, CDC25B, CYP1A1, CYP1A2, CYP2A6, CYP2C19, DUSP3, EGFR, ESR1, ESR2, ESRRB, GSK3B, HSPA1A, KCNH2, MET, NR3C1, PGR, PPARA, PTGS2, PTPN1, SLC6A4, SMAD3, SRC, TEK |
4.84187 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, ADRA2A, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SMAD3, SRC |
4.68562 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP2C19 |
4.41516 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIM1, SRC, TEK |
4.04436 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, CBR1, HSD17B1, HSD17B2, XDH |
3.73638 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADRA2A, AOX1, APP, CSNK2A1, EGFR, ESR1, ESR2, FLT3, IGF1R, KCNH2, KDR, MET, MMP9, PGR, PTGS2, SLC6A4, SMAD3, TERT, TYR, XDH |
3.63752 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.61438 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, ADRA2A, AOX1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DHFR, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GSK3B, HSD17B1, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP12, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
3.52767 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIM1, SRC, TEK, TERT |
3.44802 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX15, ALOX5, IDO1, PTGS2 |
3.40188 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX15, ALOX5, IDO1, PTGS2 |
3.3398 |
[MF] GO:1901363 |
heterocyclic compound binding
|
ADORA1, AOX1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DHFR, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GSK3B, HSD17B1, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP12, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
3.31487 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.25679 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, XDH |
3.256 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.85638 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.85638 |
[MF] GO:0008013 |
beta-catenin binding
|
AR, CSNK2A1, ESR1, GSK3B, SMAD3 |
2.74604 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.61656 |
[MF] GO:0000978 |
None
|
AR, ESR1, ESR2, ESRRA, NR3C1, PGR, PPARA, RORC, SMAD3 |
2.58225 |
[MF] GO:0008392 |
None
|
CYP2A13, CYP2A6, CYP2C19 |
2.50675 |
[MF] GO:0008391 |
None
|
CYP2A13, CYP2A6, CYP2C19 |
2.50675 |
[MF] GO:0050473 |
arachidonate 15-lipoxygenase activity
|
ALOX15, PTGS2 |
2.46504 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A4 |
2.46504 |
[MF] GO:0047374 |
None
|
CES1, CES2 |
2.46504 |
[MF] GO:0000987 |
None
|
AR, ESR1, ESR2, ESRRA, NR3C1, PGR, PPARA, RORC, SMAD3 |
2.46397 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.33367 |
[MF] GO:0031072 |
heat shock protein binding
|
ADORA1, CSNK2A1, HSPA1A, KDR, NR3C1 |
2.32974 |
[MF] GO:0019900 |
None
|
ADRA2A, AURKB, CDC25B, DUSP3, EGFR, ESR1, GSK3B, NR3C1, PTPN1, SMAD3, SRC |
2.29005 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, F10, FLT3, GSK3B, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PTPN1, SRC, TEK |
2.2793 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.23482 |
[MF] GO:0032795 |
None
|
ADORA1, ADRA2A |
2.23482 |
[MF] GO:0051425 |
None
|
APP, INSR |
2.23482 |
[MF] GO:0001085 |
RNA polymerase II transcription factor binding
|
AR, ESR1, GSK3B, PPARA, SMAD3 |
2.16965 |
[MF] GO:0019901 |
None
|
ADRA2A, CDC25B, DUSP3, EGFR, ESR1, GSK3B, NR3C1, PTPN1, SMAD3, SRC |
2.13104 |
[MF] GO:0005518 |
collagen binding
|
ACHE, MMP12, MMP9, SMAD3 |
2.12735 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, CBR1, HSD17B1, HSD17B2 |
2.12633 |
[MF] GO:0008134 |
transcription factor binding
|
AR, ESR1, ESRRB, FLT3, GSK3B, PIM1, PPARA, SMAD3, SRC, TERT |
2.06829 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.05049 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.05049 |
[MF] GO:0046983 |
protein dimerization activity
|
ACHE, ADORA1, ADRA2A, AOX1, AR, AXL, EGFR, FLT3, KCNH2, PTGS2, SLC6A4, SMAD3, TERT, TYR, XDH |
2.0209 |